See more : HCW Biologics Inc. (HCWB) Income Statement Analysis – Financial Results
Complete financial analysis of JSC National Atomic Company Kazatomprom (KAP.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JSC National Atomic Company Kazatomprom, a leading company in the Uranium industry within the Energy sector.
- Atlantic American Corporation (AAME) Income Statement Analysis – Financial Results
- Pono Capital Two, Inc. (PTWO) Income Statement Analysis – Financial Results
- Ternium Argentina S.A. (TXAR.BA) Income Statement Analysis – Financial Results
- AXIOS Sustainable Growth Acquis (AXAC-RI) Income Statement Analysis – Financial Results
- Shenzhen Genvict Technologies Co., Ltd. (002869.SZ) Income Statement Analysis – Financial Results
JSC National Atomic Company Kazatomprom (KAP.L)
About JSC National Atomic Company Kazatomprom
JSC National Atomic Company Kazatomprom engages in the exploration, production, processing, marketing, and sale of uranium and uranium products in the Republic of Kazakhstan and internationally. It also processes rare metals; manufactures and sells beryllium, tantalum, and niobium products; provides communication and security services; and produces semiconductor materials. In addition, the company offers research, project, development, and engineering consulting services; drilling services; and procurement and transportation services, as well as monitors radiation level and environment conditions. Further, it is involved in the investment and administration of financial services. The company was founded in 1997 and is based in Nur-Sultan, the Republic of Kazakhstan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,434.64B | 1,001.17B | 691.01B | 587.46B | 502.27B | 436.63B | 336.52B | 394.32B | 383.96B | 322.75B | 288.28B |
| Cost of Revenue | 615.99B | 475.10B | 402.97B | 319.62B | 307.50B | 313.82B | 263.86B | 283.88B | 280.60B | 244.50B | 216.74B |
| Gross Profit | 818.64B | 526.07B | 288.04B | 267.83B | 194.77B | 122.82B | 72.65B | 110.43B | 103.36B | 78.25B | 71.54B |
| Gross Profit Ratio | 57.06% | 52.55% | 41.68% | 45.59% | 38.78% | 28.13% | 21.59% | 28.01% | 26.92% | 24.24% | 24.82% |
| Research & Development | 806.00M | 887.00M | 725.00M | 505.00M | 499.00M | 230.00M | 32.00M | 89.00M | 695.00M | 572.00M | 1.74B |
| General & Administrative | 23.72B | 13.23B | 10.32B | 8.14B | 9.08B | 8.52B | 7.45B | 8.86B | 5.14B | 17.79B | 27.45B |
| Selling & Marketing | 26.46B | 23.59B | 14.08B | 13.03B | 9.65B | 9.41B | 4.13B | 5.47B | 3.15B | 4.27B | 3.78B |
| SG&A | 50.18B | 36.82B | 24.40B | 21.17B | 18.73B | 17.93B | 11.58B | 14.33B | 8.29B | 23.17B | 31.38B |
| Other Expenses | 0.00 | 34.09B | 27.86B | 23.47B | 24.84B | 28.03B | 24.15B | 22.95B | 20.58B | 0.00 | 0.00 |
| Operating Expenses | 82.77B | 71.79B | 52.99B | 45.15B | 44.08B | 46.18B | 35.76B | 37.36B | 29.57B | 53.41B | 24.25B |
| Cost & Expenses | 698.76B | 546.89B | 455.96B | 364.77B | 351.57B | 360.00B | 299.63B | 321.25B | 310.17B | 297.91B | 240.99B |
| Interest Income | 25.65B | 12.51B | 5.20B | 4.26B | 3.79B | 3.35B | 4.55B | 5.29B | 2.90B | 5.15B | 3.49B |
| Interest Expense | 7.39B | 6.58B | 5.81B | 6.97B | 10.20B | 10.94B | 7.07B | 7.67B | 7.47B | 0.00 | 0.00 |
| Depreciation & Amortization | 2.34B | 2.34B | 2.83B | 1.98B | 1.78B | 875.00M | 911.00M | 1.15B | 1.41B | 23.22B | 26.56B |
| EBITDA | 739.29B | 592.63B | 290.28B | 294.04B | 190.29B | 464.26B | 161.88B | 138.36B | 58.43B | 57.99B | 35.36B |
| EBITDA Ratio | 51.53% | 58.57% | 42.41% | 46.11% | 37.89% | 94.55% | 48.72% | 34.39% | 15.72% | 17.97% | 12.27% |
| Operating Income | 735.87B | 584.09B | 290.21B | 268.91B | 188.51B | 76.63B | 36.89B | 73.07B | 73.80B | 34.76B | 8.81B |
| Operating Income Ratio | 51.29% | 58.34% | 42.00% | 45.77% | 37.53% | 17.55% | 10.96% | 18.53% | 19.22% | 10.77% | 3.05% |
| Total Other Income/Expenses | -7.53B | 96.41B | 18.00B | 36.83B | 58.75B | 331.33B | 122.61B | 56.47B | -24.25B | -34.81B | 35.00B |
| Income Before Tax | 728.34B | 583.71B | 281.64B | 285.14B | 247.26B | 407.96B | 156.62B | 129.54B | 49.55B | 19.69B | 43.81B |
| Income Before Tax Ratio | 50.77% | 58.30% | 40.76% | 48.54% | 49.23% | 93.43% | 46.54% | 32.85% | 12.90% | 6.10% | 15.20% |
| Income Tax Expense | 148.01B | 110.74B | 61.62B | 63.78B | 33.51B | 28.80B | 17.46B | 17.99B | 13.04B | 4.44B | 7.28B |
| Net Income | 419.18B | 472.96B | 220.03B | 183.54B | 190.00B | 372.18B | 138.53B | 108.80B | 38.44B | 15.49B | 35.90B |
| Net Income Ratio | 29.22% | 47.24% | 31.84% | 31.24% | 37.83% | 85.24% | 41.16% | 27.59% | 10.01% | 4.80% | 12.45% |
| EPS | 1.62K | 1.82K | 848.35 | 708.00 | 733.00 | 1.44K | 534.00 | 419.48 | 148.22 | 60.31 | 139.79 |
| EPS Diluted | 1.62K | 1.82K | 848.35 | 708.00 | 733.00 | 1.44K | 534.00 | 419.48 | 148.22 | 60.31 | 139.79 |
| Weighted Avg Shares Out | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 256.84M | 256.84M |
| Weighted Avg Shares Out (Dil) | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 259.36M | 256.84M | 256.84M |
Source: https://incomestatements.info
Category: Stock Reports